Mark H. Kirschbaum, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark H. Kirschbaum, M.D.
Bio Green Med Solution, Inc. reported in an 8-K filed January 30, 2024 that Mark H. Kirschbaum, M.D. was terminated as Chief Medical Officer, effective January 25, 2024.
“On January 25, 2024, the employment of Mark H. Kirschbaum, M.D. as Chief Medical Officer of Cyclacel Pharmaceuticals, Inc. (the “Company”) was terminated by the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-10-23–2024-01-25
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.